50+yrs. Virginia Cancer Specialists: Prevention. Detection. Diagnosis. Treatment. Radiation. Surgery. Clinical Trial Phase 1+/Oncology Research Space NOVA
Northern Virginia
Joined May 2016
- Tweets1.2K
- Following1K
- Followers829
- Likes643
Virginia Cancer Specialists retweeted
Practices in The Network are at the forefront of creating exciting new training opportunities. In this @GoHealio article, Dr. Youssef Charara of @vcspecialists discusses how the ASTRO program is making #RadiopharmaceuticalTherapy training more accessible. healio.com/news/hematology-o…
Virginia Cancer Specialists retweeted
New series alert! Luis E. Raez, MD, FASCO, FACP, and Alexander I. Spira, MD, PhD, FACP, FASCO, tackle frontline treatment decisions in EGFR-mutated NSCLC.
Watch all 6 episodes now. hubs.li/Q04gDGq80
@LuisRaezMD @mhshospital @AlexSpiraMDPhD @VCSpecialists #NSCLC #LungCancer #Oncology
Virginia Cancer Specialists retweeted
Excited to see this collaboration between @VCSpecialists and @hcavirginia to better serve #CellTherapy patients! Watch the video for more on this important milestone for patients in Northern Virginia: linkedin.com/posts/navneet-m…
#CARTcell #PatientCenteredCare
Virginia Cancer Specialists retweeted
Our dedicated team provides the expertise & caring support to guide you back to the moments that matter most. Take the first step toward personalized care; visit our website today: VirginiaCancerSpecialists.co… #PersonalizedCare #YourPathtoHealing #StartsHere #VirginiaCancerSpecialists
Virginia Cancer Specialists retweeted
Congrats to the 29 physicians and surgeons from @VCSpecialists who were recently named @Washingtonian Magazine's #TopDoctors of 2025! We're excited to see physicians in The Network being recognized for their dedication.
prnewswire.com/news-releases…
#HealthcareHeroes #CancerCare
Virginia Cancer Specialists retweeted
READ: @vcspecialists has started a new radiopharmaceutical trial that could make a wider range of treatment available for cancer patients. We're excited to see where this leads!
prnewswire.com/news-releases…
#CancerTreatment #Radiopharmaceuticals #ClinicalTrials
Virginia Cancer Specialists retweeted
Thank you to @AlexSpiraMDPhD, of @VCSpecialists, who spoke with us at #GI25 about findings from a phase 1 study of RMC-9805 in pancreatic cancer. Check back on our site to see a clip from this video interview! @asco #pancsm #oncology
onclive.com/conference/gi
Virginia Cancer Specialists retweeted
Congrats to the 26 physicians from @VCSpecialists who were recently named 2024 Top Doctors by Washingtonian Magazine! We're proud to work with you.
Find out more here: linkedin.com/posts/virginia-…
#TopDoctors2024 #HealthcareHeroes #HealthcareExcellence
Virginia Cancer Specialists retweeted
🎥@AlexSpiraMDPhD of @VCSpecialists highlights ctDNA as a biomarker in pancreatic cancer, aiding early response prediction before CT scans and potentially improving survival outcomes:
➡️ow.ly/Zo2550URc8Y⬅️
@asco #GI25 #Pancsm #PancreaticCancer
Virginia Cancer Specialists retweeted
WATCH: @AlexSpiraMDPhD of @VCSpecialists discusses the clinical implications of ctDNA for treatment decisions and monitoring in patients with KRAS G12D pancreatic ductal adenocarcinoma treated with zoldonrasib. #PDAC #GI25
hubs.li/Q034z-rv0
Virginia Cancer Specialists retweeted
In this video, Alex Spira, MD, PhD, discusses a subset analysis of the phase 3 MARIPOSA trial looking at dose interruptions during the course of amivantamab + lazertinib treatment for EGFR-mutant #NSCLC. #LCSM | @AlexSpiraMDPhD @VCSpecialists
targetedonc.com/view/spira-o…
Virginia Cancer Specialists retweeted
We're proud to share that 11 physicians from Virginia Oncology Associates and @VCSpecialists have been named to @VirginiaBiz's Top Doctors of 2024 list! Congratulations to these physicians on this incredible achievement. #TopDoctors #Hematology #GynOnc
Virginia Cancer Specialists retweeted
🌟Join Dipti Patel-Donnelly, MD, @VCSpecialists, managing high-risk hematologic malignancies in our communities at #ASH2023. 🎥 [Video] Check out her insights at 👉 oncologytube.com/channel/ASH… #Oncology #Hematology #CancerResearch 🩸🔬
Virginia Cancer Specialists retweeted
Tune into this #podcast episode from #ASH23 featuring Dr. Dipti Patel-Donnelly of @VCSpecialists discussing her session in which she shared pearls of #wisdom regarding optimized #management when #patients with #hematologic malignancies stay local: oncdata.com/news/managing-ac…
Virginia Cancer Specialists retweeted
Dipiti Patel Donnelly, MD, of @VCSpecialists joined us to discuss how clinicians can manage high-risk hematologic malignancies in the community. To learn more, visit onclive.com @ASH_hematology #ASH23 #oncology
Virginia Cancer Specialists retweeted
A recent study published by @VCSpecialists Dr. Dipti Patel-Donnelly and colleagues explored the efficacy of #BV in combination with #DTIC as frontline therapy for older Hodgkin lymphoma patients. The results are promising. #OncTwitter pubmed.ncbi.nlm.nih.gov/3794…
Virginia Cancer Specialists retweeted
Investigators hope that the brain penetrant, irreversible EGFR inhibitor BDTX-1535 will be able to target EGFR mutations and fill unmet needs in NSCLC and GBM. @AlexSpiraMDPhD @VCSpecialists #oncology #NSCLC onclive.com/view/bdtx-1535-s…
Virginia Cancer Specialists retweeted
Patients with NSCLC harboring acquired EGFR mutations, such as C797S and intrinsic mutations in EGFR represent underserved populations where additional targeted therapies are needed. @AlexSpiraMDPhD @VCSpecialists #oncology #NSCLC onclive.com/view/bdtx-1535-s…
Virginia Cancer Specialists retweeted
BDTX-1535 Strives to Overcome Intrinsic and Acquired EGFR Mutations in NSCLC and GBM @AlexSpiraMDPhD @VCSpecialists #oncology #NSCLC
onclive.com/view/bdtx-1535-s…
Virginia Cancer Specialists retweeted
Experts discuss results from MARIPOSA-2 and the role of amivantamab + lazertinib + chemotherapy in patients with advanced #NSCLC following progression on osimertinib. @VCSpecialists @AlexSpiraMDPhD @OncBrothers
targetedonc.com/view/maripos…
